In Dr. Ling-Jian Meng's lab at the University of Illinois, researchers are developing advanced imaging technology to explore brain functions. This work focuses on creating a new SPECT imaging system that will allow for detailed visualization of various brain activities by using different tracers. The goal is to understand how blood flow, oxygen levels, and neuron metabolism work together in both healthy and diseased brains when subjected to different cognitive and physical challenges.

Dr. Nicholas C. Wu's lab focuses on understanding how human antibodies recognize and bind to various antigens, which is essential for developing effective vaccines and therapies. They employ a high-throughput method to study the interactions between antibodies and influenza A virus proteins, aiming to predict antibody epitope specificity based on their amino acid sequences. This research could enhance our knowledge of the human immune system and inform better approaches to fight against pathogens.

Dr. Christopher Byron Brooke's lab at the University of Illinois focuses on understanding how the immune system responds to influenza viruses. By studying how the virus interacts with the immune system during natural infections, the lab aims to identify key factors that influence how effectively vaccines can prevent severe infections and transmission. Their work combines clinical research with computational modeling to improve future vaccine development and public health strategies.

Dr. Maria Christina White's lab at the University of Illinois focuses on developing new chemical reactions that can modify complex molecules in efficient ways. By designing advanced metal catalysts, the team aims to enable late-stage functionalization in drug discovery, allowing for direct changes to drug structures without lengthy synthesis. This research is important for speeding up the creation of new therapeutics and exploring natural products as potential drug candidates.

Dr. Halil Kilicoglu's research focuses on improving the understanding and application of complementary medicine (CM) in healthcare. His lab develops advanced computational tools to analyze and integrate diverse research findings on CM, enabling clinicians to access reliable information for patient care. By utilizing natural language processing and creating knowledge graphs, the lab aims to transform unstructured medical literature into structured resources that support evidence-based practice.

Dr. Haohua Tu's lab focuses on improving the success rates of assisted reproductive technologies (ART), like in vitro fertilization (IVF), through advanced imaging techniques. By developing a method called multiplexed optical metabolic imaging (MOMI), the lab aims to combine detailed insights into an embryo's structure and metabolism, which could lead to better assessments of embryo viability. Ultimately, this research could enhance the chances of successful pregnancies from embryo transfers, benefiting both humans and livestock.

Dr. Weiping Zhang's lab focuses on developing a novel vaccine called MecVax to combat diarrheal diseases caused by enterotoxigenic Escherichia coli (ETEC), which significantly affects children in developing countries. The lab's long-term goal is to create effective vaccines against major bacterial pathogens to reduce childhood mortality and improve health outcomes. This promising vaccine aims to offer broad protection by targeting multiple ETEC components, making it a significant advancement in public health.

Dr. Jodi A. Flaws' lab at the University of Illinois focuses on the impact of environmental chemicals, specifically phthalates and endocrine disrupting chemicals (EDCs), on female reproductive health. The lab investigates how these chemicals contribute to early reproductive aging, which can lead to issues like infertility and other health complications in midlife women. By using advanced techniques to understand the mechanisms behind EDC-induced ovarian damage, the lab aims to identify potential treatments and preventive strategies.

Dr. Christopher A. Gaulke's lab investigates how exposure to common herbicides during development may affect our gut microbiome and, consequently, our health, particularly in relation to obesity. The lab aims to understand the biological pathways through which these chemicals disrupt microbial communities in our intestines and contribute to weight gain. The research combines various experimental techniques to link changes in the microbiome with physiological outcomes related to obesity.

Dr. Thomas Gaj's lab focuses on developing innovative gene-editing therapies for amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease caused by mutations in the SOD1 gene. Using a cutting-edge technique called CRISPR base editing, the lab aims to safely and effectively turn off the production of harmful mutant proteins in the nervous system. Their work not only targets ALS but also paves the way for potential treatments for other neurological disorders.

Dr. Howard Gritton's lab at the University of Illinois at Urbana-Champaign focuses on understanding how exposure to certain environmental chemicals, particularly phthalates, impacts brain development and behavior. The research aims to reveal the connections between these exposures and social behavior changes, especially in relation to autism spectrum disorders. By studying animal models, the lab investigates how these chemicals might alter brain connectivity and gene expression tied to social behavior.

Dr. Bumsoo Han's lab focuses on developing new treatment strategies for pancreatic ductal adenocarcinoma (PDAC) by altering the tumor's surrounding environment, known as the stroma. The researchers are investigating the role of the coagulation system in the tumor microenvironment and how targeting specific components can enhance drug delivery and combat resistance. By understanding these interactions, the lab aims to improve therapeutic outcomes for patients with pancreatic cancer.

Dr. Brendan A. Harley's lab focuses on developing advanced biomaterials to study two significant areas: the generation of blood and immune cells from stem cells in the bone marrow and the mechanisms driving the initiation of endometriosis lesions. By creating tissue engineering models that mimic the body's natural processes, the lab aims to enhance our understanding of hematopoiesis and endometrioma formation. This research has important implications for improving treatments for blood disorders and endometriosis, which are major health issues.

Dr. Jing Yang's lab at the University of Illinois is focused on understanding the critical processes that occur during the transition from oocyte to embryo, specifically in vertebrates like frogs and zebrafish. They investigate how the cellular components and maternal RNA are reorganized to support successful reproduction. Their research aims to uncover new mechanisms that could explain unexplained infertility in humans, enhancing reproductive health.

Dr. Zhi-Pei Liang's lab at the University of Illinois focuses on developing advanced imaging technologies to better understand brain diseases. Their innovative work involves creating a new imaging method that can capture multiple brain characteristics at once, allowing for faster and more detailed assessments of brain health. This research is aimed at improving diagnoses and treatment strategies in personalized medicine.

Dr. Bo Wang's lab focuses on understanding how certain proteins in liver cells influence the metabolism of lipids, specifically cholesterol and triglycerides. This research is essential for tackling cardiovascular diseases like atherosclerosis, which is linked to high levels of these lipids in the blood. By studying the role of the SEC16B protein, the lab aims to identify new therapeutic targets that could help reduce the risk of developing heart-related health issues.

Dr. Huimin Zhao's lab focuses on discovering new antibiotics from natural products, particularly a special group called ribosomally synthesized and post-translationally modified peptides (RiPPs). By using advanced technologies like artificial intelligence and synthetic biology, they aim to enhance the production of these promising compounds and improve the ability to predict their structures. The research ultimately seeks to address the growing problem of antibiotic resistance by developing new antibacterial agents.

Dr. Michael Oelze's lab at the University of Illinois focuses on advancing ultrasound technology by developing a low-cost, high-channel count research platform for 3D volumetric imaging. Their work aims to make real-time and ultrafast imaging more accessible for research and clinical applications. By creating a user-friendly and open-source platform, the lab hopes to improve the quality and affordability of advanced ultrasound techniques.

Dr. James A. Imlay's lab studies how bacteria cope with the challenges posed by oxygen and reactive oxygen species. Bacteria have evolved various defenses to counteract the damaging effects of oxidative stress that can harm their enzymes and DNA. By investigating how different bacteria produce and manage reactive oxygen species, the lab aims to enhance our understanding of bacterial survival and adaptation in oxygen-rich environments, potentially leading to better antibiotic development.

Dr. Catharine Fairbairn's research focuses on understanding how stress influences people's drinking habits, especially in social situations. Her lab investigates why individuals might turn to alcohol during stressful times and how this might lead to alcohol use disorder. By using innovative methods like brain imaging and real-life assessments, the lab aims to uncover the psychological mechanisms behind alcohol's rewarding effects, which could help improve prevention and treatment strategies for drinking problems.